AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 13, 2024
The analysis included health information from 273,260 female participants in the United Kingdom Biobank, and the findings suggest that those who start their period younger and go […]
Crucial Data Soutions
JUNE 28, 2021
It’s 2021 and sharpies are still being used to write on bio sample tubes in most clinical trials…. As most people would agree, one core tenant of a well-run clinical trial is accurately collecting, handling and analyzing bio samples from subjects during the study. Background.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 18, 2023
Pharmaceutical companies and biotechs are also adapting their approaches, launching patient finding and engagement programmes that can start years before clinical trials begin and allow them to run ‘recontact by genotype’ studies that the Resilience Project would have liked to do. Giving participants something in return.
Advarra
FEBRUARY 13, 2024
Every day, clinical research organizations work to deliver a seamless user experience for their staff, while also providing robust security measurements to protect their data and stay compliant. Having SSO available via cellular device enables easy and secure access to research systems.
The Pharma Data
JANUARY 31, 2021
“You might not see it immediately because many of these larger companies happen to also have their own internal biobanks, so they are not entirely reliant on primary acquisition of samples on the outside,” Ianelli said. I think it’s also important to think about the definition of biobanks. It has made research more immediate.
XTalks
FEBRUARY 4, 2021
Generation of strong research dataset cohorts must begin with high-quality clinical samples. Biobanks are used for the coordination of high-yield patient sample collection. There are a number of complexities associated with the collection, banking and distribution of clinical samples. Biobanking Models.
The Pharma Data
AUGUST 30, 2021
MADRID-COVID is a randomized clinical trial conducted in close collaboration between the CNIC and cardiology, ICU, pulmonology, and biobank services at FJD Hospital. The study is a prime example of collaboration between basic and clinical researchers.
Expert insights. Personalized for you.
178 
Let's personalize your content